A Positive Test for Hypercoagulability
Presence of factor V Leiden (can be heterozygous or homozygous)
Presence of prothrombin 20210 mutation (can be heterozygous or homozygous)
Presence of antiphospholipid antibody; could be manifested as lupus anticoagulant or anticardiolipin antibodies or anti-beta 2 glycoprotein 1 antibodies (IgG, IgM, IgA)
Deficiency of protein C not produced by Coumadin or other acquired cause
Deficiency of protein S not produced by Coumadin or other acquired cause
Deficiency of antithrombin not produced by heparin or low-molecular-weight heparin therapy or other acquired cause
Suggested Additional Lab Testing
Test for activated protein C resistance as a screening test for factor V Leiden mutation.
If screening test suggests a heterozygous or homozygous form of factor V Leiden mutation, perform a genetic test to determine zygosity.
If lupus anticoagulant is present, the activated protein C resistance test will suffer interference; only the genetic test for factor V Leiden should be performed in this circumstance.
Perform genetic test for prothrombin 20210 mutation; there is no simple screening test for this abnormality.
Test for antiphospholipid antibody, both for lupus anticoagulant and anticardiolipin antibodies, and/or anti-beta 2 glycoprotein 1 antibodies (IgG and IgM at least).
Test for protein C functional activity; if the functional activity is low, test for protein C antigen to reveal type of protein C deficiency.
Test for protein S either by functional assay or free antigen assay; if there is a deficiency, measure total protein S antigen to type a congenitally low protein S patientt. Test for antithrombin functional activity; if it is low in absence of heparin, measure antithrombin antigenic activity to type the deficiency.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Next Article in LabMed
Neurology Advisor Articles
- Rasagiline Plus Riluzole is Safe, May Improve Survival in ALS
- Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines
- Gender Differences in the Epidemiology of Migraine
- Changes in Glucose Regulation in Parkinson Disease
- Apomorphine Infusions Improves Off Time Associated With Parkinson Disease
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura
- Associations Identified Between Stroke Severity, Recovery of Visuospatial Neglect
- Action Tremor May Have Central Origin in Motor Neuron Disease
- Characteristics Affecting Health-Related Quality of Life in RRMS, Progressive MS
- Neurodevelopmental Anomalies, Birth Defects Linked to Zika ID'd